StonvexLoading…
StonvexStonvexStonvexCore line items from ITW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.04B | $15.90B | $16.11B | $15.93B |
Operating Income | $4.22B | $4.26B | $4.04B | $3.79B |
Net Income | $3.07B | $3.49B | $2.96B | $3.03B |
EPS (Diluted) | $10.49 | $11.71 | $9.74 | $9.77 |
Total Assets | $16.15B | $15.07B | $15.52B | $15.42B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $851.00M | $948.00M | $1.06B | $708.00M |
Free Cash Flow OCF − CapEx | $2.71B | $2.84B | $3.08B | $1.94B |
Shares Outstanding | 288.60M | 294.00M | 299.30M | 305.00M |